Bristol-Myers Squibb received FDA's approval for Cobenfy, which is poised to be a game changer in the treatment of ...

Tempus AI has announced an expanded collaboration with Takeda to enhance oncology research and development. The partnership ...

In today's healthcare environment, physicians face numerous challenges that significantly impact their professional lives and personal well-being. Among these, the complexities of electronic medical r ...

Citing fears of vertical integration and reduced competition, anti-monopoly advocacy group American Economic Liberties ...

These dedicated nursing roles can enhance care management of hospitalized patients undergoing radiotherapy and improve ...

Morgan Stanley analyst Judah Frommer maintained a Buy rating on Mural Oncology Plc (MURA – Research Report) yesterday and set a price ...

Ulster Hospital’s Lead Oncology Clinical Pharmacist John Houston has described, the at times, unseen role he and his team ...

AstraZeneca is extending its work with Immunai through a multiyear collaboration that aims to implement its ...

On Thursday, Pyxis Oncology Inc (PYXS) stock saw a modest uptick, ending the day at $3.72 which represents a slight increase of $0.21 or 5.98% from the prior close of $3.51. The stock opened at $3.52 ...

Sam Slutsky, an analyst from LifeSci Capital, maintained the Buy rating on CG Oncology, Inc. (CGON – Research Report). The associated ...

Community Oncology Partners (COP), the owner-operator of medical oncology practices bringing the fight against cancer closer to home, today announced a partnership with House Rx, the leader in ...

Cardinal Health says the transaction is part of its effort to help community healthcare providers maintain their independence ...